USA flag logo/image

An Official Website of the United States Government

Implantable Noise-Based Sensory Enhancement Devices

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
54659
Program Year/Program:
2001 / SBIR
Agency Tracking Number:
1R43NS042560-01
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
AFFERENT CORPORATION
AFFERENT CORPORATION BOX 160, 3 DAVOL SQ, STE C200 PROVIDENCE, RI 02903
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2001
Title: Implantable Noise-Based Sensory Enhancement Devices
Agency: HHS
Contract: N/A
Award Amount: $100,000.00
 

Abstract:

Stochastic resonance (SR) is a counterintuitive phenomenon in which slight amounts of noise imparted to a system actually increase its sensitivity to weak stimuli. SR has been shown to produce a demonstrable effect in human sensory cells. In both healthy young and clinical subjects - elderly, diabetics, and stroke sufferers - a notable increase in tactile and proprioceptive sensitivity is seen when electrical or mechanical noise is presented at the site of the stimulus. Dysfunction in these sensory systems is known to have significant clinical sequellae including gait abnormalities, propensity to fall, and foot ulcers. Together, these conditions cost the U.S. healthcare system many billions of dollars annually. The proposed research will initiate a development program whose ultimate goal is to produce fully implantable medical devices that capitalize on this effect to treat certain types of sensory dysfunction. In an acute in-vivo animal model, we will test the hypothesis that sub- sensory noise delivered via subcutaneous electrodes placed near mechanoreceptors in the lower leg improves the ability of those receptors to discern slight rotations about the ankle. Direct recordings will be made of afferent nerve signals from those mechanoreceptors. We will also assess whether the receptors adapt to the noise stimulation, rendering it ineffective over time. PROPOSED COMMERCIAL APPLICATIONS: If successful, the proposed research can lead to implantable medical devices that improve somatosensory sensitivity in people who suffer from peripheral neuropathy. This would improve quality of life for these individuals while reducing the costs of caring for them. Applications include uses in improving gait and balance, some forms of incontinence, and rehabilitation medicine.

Principal Investigator:

Jason D. Harry

Business Contact:


4014539933
JASON_HARRY@SENSORYTECHINC.COM
Small Business Information at Submission:

SENSORY TECHNOLOGIES, INC.
194 WATERMAN ST PROVIDENCE, RI 02906

EIN/Tax ID: 050507798
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No